Life Sciences
& HealthTech
Cutting-edge therapeutics, digital health and healthcare innovation are being developed at a record pace. Global leaders and disruptors alike are contributing to this transformation and Orrick is helping them protect their innovations, invest and scale.
What We Do
Who We Serve
Who We Are
Our Results
biotech
& pharma
digital
health
research
& Labs
Medical
Devices
Diagnostics
& tools
Developing and Patenting AI Inventions: 5 Things for Biotech Companies to Consider
OCT 2024 | 5 MIN READ
Insights
SUBSCRIBE FOR UPDATES
Get In Touch
see full team
Tools for Startups
David Gindler
get in touch
Thora Johnson
Stephen Thau
Our Team &
What We Do
See full team
U.S. States Begin Regulating Generative Artificial Intelligence in Health Care
OCt 2024 | 3 min read
Navigating University Licensing for Startups: Key Considerations
SEPT 2024 | 4 min read
Our quarterly series with Pitchbook reviews financing trends in the life sciences and healthtech industry and key verticals such as women’s health, AI in drug discovery, mental health and more.
Learn more
Litigation
Insights
Our team & what we do
Tools for startups
Get in touch
12/20
largest biopharma companies
350+
venture-backed companies
in life sciences, healthtech and digital health as well as leading investors
20%
of our work
in corporate, commercial/products liability litigation and IP litigation is for Life Sciences & HealthTech companies
50
partners globally
fully dedicated to Life Sciences & HealthTech
19
markets served
worldwide
65
technical degrees
in life sciences and engineering, including 7 PhDs
Top 5
for venture capital for 7 straight years
with special recognition in Pharma and Biotech, Healthcare Devices, and Healthcare and Health Systems (Pitchbook)
$6.3B+
in Life Sciences & HealthTech transactions
including 81 venture financings in 7 countries and 17 M&A transactions in 12 countries in 2023
Litigation & IP Litigation Department of the Year finalist
only firm recognized on both lists in 2023 (American Lawyer)
270+
patent litigations
164 PTAB proceedings, 18 ITC investigations and 32 Federal Circuit Appeals since 2019
86.4%
win rate for patentees before the IPR
substantially above the industry average
Visit our self-service platform with legal and business resources to help your business scale, grow and thrive at all stages.
Visit the Studio
get in touch
get in touch
in the U.S. and dozens of fast-growing public companies
SEE ALL INSIGHTS
SIGN UP FOR UPDATES
Industry leaders and life sciences disruptors rely on our team for their most complex litigation, including in:
IP, product liability, employment and white-collar disputes Appellate courts nationwide – where we have established important industry precedent Arbitral tribunals around the world
IP Litigation
Our IP and appellate teams represent life sciences innovators in their highest-stakes disputes, including:
BPCIA and Hatch-Waxman litigation
Innovator vs. innovator biopharma litigation
Emerging fields of innovation, including CRISPR, CAR T and bispecific antibody disputes
Corporate & Venture Capital
We serve innovative startups and high-growth companies in all aspects of their operations, including:
Formation, corporate governance and day-to-day legal matters
Public and private equity and debt financing, preferred stock financings and public offerings
M&A and strategic licensing transactions
Regulatory
We deliver forward-looking solutions for regulatory compliance at the state and federal level, including:
Determining FDA preclearance obligations
Navigating corporate practice of medicine considerations
Assessing HIPAA, state consumer privacy and health laws
Integrating generative AI in consumer products
Litigation
•
•
•
•
•
•
BPCIA and Hatch-Waxman litigation Innovator vs. innovator biopharma litigation Emerging fields of innovation, including CRISPR, CAR T and bispecific antibody disputes
Determining FDA preclearance obligations Navigating corporate practice of medicine considerations Assessing HIPAA, state consumer privacy and health laws Integrating generative AI in consumer products
•
•
•
•
Formation, corporate governance and day-to-day legal matters Public and private equity and debt financing, preferred stock financings and public offerings M&A and strategic licensing transactions
•
•
•
Proposed PTO Rule Poses Threat to Patent Practice and Could Stifle Innovation
JUNE 2024 | 1 min read
State of the States: 2024 Elections
NOV 2024 | 10 MIN READ
Proposed PTO Rule Poses Threat to Patent Practice and Could Stifle Innovation
JUNE 2024 | 1 min read
Developing and Patenting AI Inventions: 5 Things for Biotech Companies to Consider
OCT 2024 | 5 min read